Immunovia Balance Sheet Health
Financial Health criteria checks 4/6
Immunovia has a total shareholder equity of SEK43.7M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK71.0M and SEK27.3M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr51.18m |
Equity | kr43.70m |
Total liabilities | kr27.33m |
Total assets | kr71.02m |
Recent financial health updates
Here's Why We're Watching Immunovia's (STO:IMMNOV) Cash Burn Situation
Apr 20We're Keeping An Eye On Immunovia's (STO:IMMNOV) Cash Burn Rate
Dec 09Is Immunovia (STO:IMMNOV) In A Good Position To Invest In Growth?
May 13Here's Why We're Not Too Worried About Immunovia's (STO:IMMNOV) Cash Burn Situation
Jan 18We Think Immunovia (STO:IMMNOV) Can Afford To Drive Business Growth
Aug 28Here's Why We're Not Too Worried About Immunovia's (STO:IMMNOV) Cash Burn Situation
Feb 03Recent updates
Here's Why We're Watching Immunovia's (STO:IMMNOV) Cash Burn Situation
Apr 20We're Keeping An Eye On Immunovia's (STO:IMMNOV) Cash Burn Rate
Dec 09Is Immunovia (STO:IMMNOV) In A Good Position To Invest In Growth?
May 13Here's Why We're Not Too Worried About Immunovia's (STO:IMMNOV) Cash Burn Situation
Jan 18We Think Immunovia (STO:IMMNOV) Can Afford To Drive Business Growth
Aug 28What Kind Of Investors Own Most Of Immunovia AB (publ) (STO:IMMNOV)?
Mar 09Here's Why We're Not Too Worried About Immunovia's (STO:IMMNOV) Cash Burn Situation
Feb 03Immunovia AB (publ)'s (STO:IMMNOV) Intrinsic Value Is Potentially 72% Above Its Share Price
Dec 30Insider Buying: The Immunovia AB (publ) (STO:IMMNOV) Director Just Bought kr293k Worth Of Shares
Dec 03Financial Position Analysis
Short Term Liabilities: IMMNOV's short term assets (SEK55.6M) exceed its short term liabilities (SEK27.3M).
Long Term Liabilities: IMMNOV has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: IMMNOV is debt free.
Reducing Debt: IMMNOV has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IMMNOV has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: IMMNOV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.4% each year